Among the HBeAg (+) CHB patients, the mean levels of qAnti-HBc for different stages of fibrosis were as follows: S0–1 (3.84 ± 1.14 log10IU/mL), S2 (4.54 ± 0.73 log10IU/mL), S3 (4.70 ± 0.68 log10IU/mL) and S4 (4.63 ± 0.74 log10IU/mL). Here, KRT88P is linked to fibrosis.